Daratumumab for Antibody-mediated Rejection in Heart Transplant—A Novel Therapy: Successful Treatment of Antibody-mediated Rejection
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Transplantation
Reference5 articles.
1. Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors.;de Weers;J Immunol,2011
2. Daratumumab in sensitized kidney transplantation: potentials and limitations of experimental and clinical use.;Kwun;J Am Soc Nephrol,2019
3. Current challenges and opportunities in the management of antibody-mediated rejection in lung transplantation.;Hulbert;Curr Opin Organ Transplant,2018
4. The 2013 International Society for Heart and Lung Transplantation Working Formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation.;Berry;J Heart Lung Transplant,2013
5. Antibody-mediated rejection in cardiac transplantation: emerging knowledge in diagnosis and management: a scientific statement from the American Heart Association.;Colvin;Circulation,2015
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Clinical Outcomes After a Biopsy Diagnosis of Antibody-mediated Rejection in Pediatric Heart Transplant Recipients;The Journal of Heart and Lung Transplantation;2024-09
2. Advances in understanding and managing pediatric heart failure and transplant;Current Opinion in Pediatrics;2024-08-13
3. Open-Label Phase 1/2 Study of Daratumumab-Based Desensitization Before Kidney Transplantation;Kidney International Reports;2024-08
4. The use of haploidentical stem cell transplant as an alternative donor source in patients with decreased access to matched unrelated donors;Hematology;2024-05-16
5. Daratumumab treatment in six highly sensitised solid organ transplant recipients: A case series and literature review;HLA;2024-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3